


| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Magnesium Sulfate Hydrate | Magnesium Sulfate Hydrate Injection | Solution for Injection | Shortage | 2026-03-12 |
| Inactivated Influenza Virus Antigen Type B [B/Austria/1359417/2021 BVR-26], Purified Inactivated Influenza Virus Antigen Type A [A/Victoria/4897/2022 IVR-238(H1N1)], Purified Inactivated Influenza Virus Antigen Type B [B/Phuket/3073/2013 BVR-1B],Purified inactivated influenza virus antigen type A [A/Croatia/10136RV/2023 X-425A(H3N2)] | FluadQuad Prefilled Syringe (Influenza Surface Antigen MF59C.1 Adjuvant Vaccine) | Suspension for Injection | Discontinued | 2026-03-12 |
| Fluticasone furoate (undifferentiated), Vilanterol trifenatate (undifferentiated), Umeclidinium bromide (undifferentiated) | Trelige Ellipta | Metered-dose inhaler, powder | Shortage | 2026-03-12 |
| Benzidamine hydrochloride, cetylpyridinium chloride hydrate | Mogle One Q Spray | Oral solution | Shortage | 2026-03-11 |
| Lidocaine, acrinol hydrate | Seonggwang Lidocaine Gargle | Patch with carrier | Discontinued | 2026-03-11 |
| White Vaseline | Sungkwang Sterile Vaseline Gauze (White Vaseline) | Drug-impregnated gauze | Discontinued | 2026-03-11 |
| Acyclovir | Citavic Oral Adhesive Tablets (Acyclovir) | Oral lozenges | Discontinued | 2026-03-05 |
| Allergen extract | NovoHeligen Depot Maintenance Treatment A | Solution for Injection | Discontinued | 2026-03-04 |
| Milnacipran Hydrochloride | Ixel Capsules 12.5 mg (Milnacipran Hydrochloride) | Hard capsule, acid-soluble | Discontinued | 2026-03-04 |
| Allergen extract | Novohygen Depot Initial Treatment A | Solution for Injection | Discontinued | 2026-03-04 |
| Active ingredients | Status | Update | Specialty |
| bromocriptine (mesylate) | Supply tension | 13/03/2026 | Parlodel 5 mg and 10 mg, capsule |
| bromocriptine (mesylate) | Supply tension | 13/03/2026 | Parlodel 2.5 mg, scored tablet |
| fluorouracil | Return to availability | 13/03/2026 | Fluorouracil Accord 50 mg/mL, solution for dilution for infusion, 5 mL, 20 mL, and 100 mL vials |
| fluorouracil | Supply tension | 13/03/2026 | Pfizer Fluorouracil 50 mg/mL, solution for dilution for infusion 20 mL and 100 mL vials |
| caffeine / phenobarbital | Supply tension | 12/03/2026 | Alepsal, tablet |
| ritonavir | Stock shortage | 12/03/2026 | Ritonavir Viatris 100 mg, film-coated tablet |
| aprepitant | Supply tension | 09/03/2026 | Emend 125 mg, powder for oral suspension |
| cefuroxime axetil | Stock shortage | 06/03/2026 | Zinnat 125 mg/5 mL for children and infants, granules for oral suspension in a bottle |
Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
| sunitinib | Capsule | 37.5 mg | Current | Limited Availability | Manufacturing | 13/03/2026 |
| moxonidine | Tablet, film coated | 200 microgram | Resolved | Available | Commercial Changes / Commercial viability | 13/03/2026 |
| moxonidine | Tablet, film coated | 400 microgram | Resolved | Available | Commercial Changes / Commercial viability | 13/03/2026 |
| Interferon gamma1b | Injection, solution | 4 million IU/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 13/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Oral Liquid, solution | 66 g~10 g | Current | Unavailable | Manufacturing | 13/03/2026 |
| Black snake antivenom | Injection, concentrated | 18000 U | Current | Limited Availability | Manufacturing | 13/03/2026 |
| itraconazole | Capsule | 100 mg | Anticipated | Available | Manufacturing | 13/03/2026 |
| rizatriptan benzoate | Tablet, orally disintegrating | 14.53 mg | Anticipated | Available | Manufacturing | 13/03/2026 |
| amidotrizoate meglumine~sodium amidotrizoate | Injection, intravenous infusion | 260 mg/mL~40 mg/mL | Current | Unavailable | Manufacturing | 13/03/2026 |
| sodium amidotrizoate~amidotrizoate meglumine | Injection, solution | 40 mg/mL~260 mg/mL | Current | Unavailable | Manufacturing | 13/03/2026 |
| doxorubicin hydrochloride | Injection | 2 mg/mL | Anticipated | Available | Manufacturing | 13/03/2026 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Limited Availability | Manufacturing | 13/03/2026 |
| montelukast sodium | Tablet | 10.4 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 13/03/2026 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Current | Unavailable | Manufacturing | 13/03/2026 |
| codeine phosphate hemihydrate | Oral Liquid, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 13/03/2026 |
| deferasirox | Tablet, film coated | 180 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 10.844 mg | Current | Limited Availability | Manufacturing | 12/03/2026 |
| propofol | Injection, intravenous infusion | 10 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 12/03/2026 |
| dimethyl fumarate | Capsule, enteric | 240 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| teriflunomide | Tablet, film coated | 14 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| bortezomib | Injection, solution | 3.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 12/03/2026 |
| risperidone | Tablet, film coated | 2 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| moxonidine | Tablet, film coated | 400 microgram | Current | Unavailable | Manufacturing | 12/03/2026 |
| olmesartan medoxomil~amlodipine besilate | Tablet, film coated | 20 mg~6.935 mg | Resolved | Available | Manufacturing | 12/03/2026 |
| pregabalin | Capsule, hard | 25 mg | Resolved | Available | Manufacturing | 12/03/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 172.95 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| pregabalin | Capsule, hard | 150 mg | Resolved | Available | Unexpected increase in consumer demand | 12/03/2026 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| ethinylestradiol~levonorgestrel | Tablet, uncoated | 30 microgram~150 microgram | Current | Unavailable | Manufacturing | 12/03/2026 |
| perindopril erbumine | Tablet | 2 mg | Current | Limited Availability | Manufacturing | 12/03/2026 |
| sertraline hydrochloride | Tablet, film coated | 112 mg | Current | Limited Availability | Manufacturing | 12/03/2026 |
| memantine hydrochloride | Tablet, film coated | 20 mg | Resolved | Available | Manufacturing | 12/03/2026 |
| olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~12.5 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| mirtazapine | Tablet, film coated | 15 mg | Current | Unavailable | Manufacturing | 12/03/2026 |
| moxonidine | Tablet, film coated | 200 microgram | Current | Unavailable | Manufacturing | 12/03/2026 |
| perindopril erbumine | Tablet | 4 mg | Anticipated | Available | Manufacturing | 12/03/2026 |
| perindopril erbumine | Tablet | 8 mg | Anticipated | Available | Manufacturing | 12/03/2026 |
| nicorandil | Tablet | 10 mg | Anticipated | Available | Unexpected increase in consumer demand | 11/03/2026 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Resolved | Available | Unexpected increase in consumer demand | 11/03/2026 |
| ketorolac trometamol | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 11/03/2026 |
| levothyroxine sodium | Tablet, uncoated | .2 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 11/03/2026 |
| bromocriptine mesilate | Tablet, uncoated | 2.87 mg | Resolved | Available | Manufacturing | 11/03/2026 |
| atomoxetine hydrochloride | Capsule, hard | 11.43 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| finasteride | Tablet, film coated | 1 mg | Current | Limited Availability | Unexpected increase in consumer demand | 11/03/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/03/2026 |
| midazolam | Injection, solution | 1 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 11/03/2026 |
| erlotinib hydrochloride | Tablet, film coated | 27.32 mg | Resolved | Available | Unexpected increase in consumer demand | 11/03/2026 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 11/03/2026 |
| azacitidine | Injection, powder for | 100 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 11/03/2026 |
| venlafaxine | Capsule, modified release | 75 mg | Current | Limited Availability | Manufacturing | 11/03/2026 |
| calcitonin salmon | Injection, solution | 100 IU/mL | Resolved | Available | Unexpected increase in consumer demand | 11/03/2026 |
| clevidipine | Injection, emulsion | 25 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 11/03/2026 |
| aripiprazole | Tablet, uncoated | 10 mg | Current | Limited Availability | Manufacturing | 11/03/2026 |
| glimepiride | Tablet, uncoated | 1 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| ropivacaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 11/03/2026 |
| sertraline hydrochloride | Tablet, film coated | 56 mg | Anticipated | Available | Manufacturing | 11/03/2026 |
| imipramine hydrochloride | Tablet, sugar coated | 10 mg | Current | Limited Availability | Manufacturing | 11/03/2026 |
| sertraline hydrochloride | Tablet, film coated | 56 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| rocuronium bromide | Injection, solution | 50 mg | Resolved | Available | Manufacturing | 11/03/2026 |
| naproxen | Tablet | 500 mg | Current | Limited Availability | Manufacturing | 11/03/2026 |
| spironolactone | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 11/03/2026 |
| labetalol hydrochloride | Tablet, film coated | 200 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Resolved | Available | Manufacturing | 11/03/2026 |
| metformin hydrochloride | Tablet, modified release | 1000 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 11/03/2026 |
| glimepiride | Tablet, uncoated | 2 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| sertraline hydrochloride | Tablet, film coated | 112 mg | Current | Unavailable | Manufacturing | 11/03/2026 |
| betahistine dihydrochloride | Tablet | 16 mg | Resolved | Available | Manufacturing | 11/03/2026 |
| clindamycin phosphate | Cream | 22.8 mg/g | Resolved | Available | Unexpected increase in consumer demand | 10/03/2026 |
| sumatriptan succinate | Tablet, film coated | 70 mg | Anticipated | Available | Commercial Changes / Commercial viability | 10/03/2026 |
| tamoxifen citrate | Tablet | 30.34 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| sunitinib | Capsule | 25 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| sunitinib | Capsule | 12.5 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| rasagiline mesilate | Tablet | 1.56 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 10/03/2026 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 10/03/2026 |
| latanoprost~timolol maleate | Eye Drops, solution | .05 mg/mL~6.83 mg/mL | Resolved | Available | Manufacturing | 10/03/2026 |
| mirtazapine | Tablet, orally disintegrating | 45 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| ropinirole hydrochloride | Tablet, film coated | .285 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| mirtazapine | Tablet, orally disintegrating | 15 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 10 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| ondansetron hydrochloride dihydrate | Injection, solution | 5 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| levetiracetam | Solution | 100 mg/mL | Current | Limited Availability | Manufacturing | 10/03/2026 |
| cyproterone acetate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| lamotrigine | Tablet, uncoated | 200 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| olanzapine | Tablet, film coated | 7.5 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| nizatidine | Capsule | 300 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| adenosine | Injection, solution | 6 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| venlafaxine hydrochloride | Capsule, modified release | 169.71 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 10/03/2026 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.76 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| fenofibrate | Tablet, film coated | 145 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| quetiapine fumarate | Tablet, modified release | 172.5 mg | Resolved | Available | Unexpected increase in consumer demand | 10/03/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| olopatadine hydrochloride | Eye Drops, solution | 1.11 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 10/03/2026 |
| pioglitazone hydrochloride | Tablet | 49.9 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| ramipril | Capsule, hard | 10 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| risperidone | Tablet, film coated | 3 mg | Resolved | Available | Manufacturing | 10/03/2026 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | .86 mg~1.71 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| flecainide acetate | Tablet | 50 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 10/03/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| phenobarbital | Tablet, uncoated | 30 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| candesartan cilexetil | Tablet, uncoated | 16 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| riluzole | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| nitrofurantoin | Capsule, hard | 50 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 22.7 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 10/03/2026 |
| methylprednisolone sodium succinate | Injection, powder for | 663.13 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 582.21 mg | Current | Limited Availability | Manufacturing | 10/03/2026 |
| levetiracetam | Injection, intravenous infusion | 100 mg/mL | Current | Limited Availability | Manufacturing | 10/03/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 21.688 mg | Anticipated | Available | Manufacturing | 10/03/2026 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 10/03/2026 |
| olanzapine | Tablet, orally disintegrating | 5 mg | Anticipated | Available | Manufacturing | 9/03/2026 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Anticipated | Available | Manufacturing | 9/03/2026 |
| mefenamic acid | Capsule, hard | 250 mg | Current | Unavailable | Manufacturing | 9/03/2026 |
| heparin sodium | Injection, solution | 10 IU/mL | Resolved | Available | Manufacturing | 9/03/2026 |
March 13, 2026
March 11, 2026
March 10, 2026
March 13, 2026
March 12, 2026
March 11, 2026
Propranolol 80mg and 160mg modified release capsules are now expected to be out of stock until July 2026.
Source: Community Pharmacy England
Cardiovascular system disorders

